SCHEMBL7048862

SCHEMBL7048862

COC(=O)CCC(=O)Nc1nc2cc(OS(=O)(=O)c3ccc(NC4CCCC4)cc3)ccc2[nH]1.COC(=O)CCCC(=O)Nc1nc2cc(OS(=O)(=O)c3ccc(NC4CCCC4)cc3)ccc2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 1/20 0.38
SPHK2 Q9NRA0 1/20 0.37
SPHK1 Q9NYA1 1/20 0.37
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
ENPP3 O14638 2/20 0.36
ENPP1 P22413 2/20 0.36
ENPP2 Q13822 2/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
MET P08581 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
CDK9 P50750 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5033481 0.98 MAPT (0.39) ALDH1A1MAPTSPHK2SPHK1NPC1
SCHEMBL5036213 0.97 ALDH1A1 (0.40) ALDH1A1TSHRHSD17B10MAPTNPC1
SCHEMBL5043032 0.91 SPHK2 (0.46) ALDH1A1MAPTSPHK2SPHK1NPC1
SCHEMBL5037959 0.90 SPHK2 (0.49) ALDH1A1MAPTSPHK2SPHK1NPC1
SCHEMBL7138529 0.89 ENPP3 (0.39) MAPTNPC1RAB9AENPP3ENPP1
SCHEMBL5037677 0.89 MET (0.45) TSHRMAPTNPC1RAB9AENPP3
SCHEMBL5033450 0.87 MAPT (0.41) MAPTNPC1RAB9AENPP3ENPP1
SCHEMBL5037847 0.85 MET (0.42) MAPTNPC1RAB9AENPP3ENPP1
SCHEMBL5043014 0.85 ENPP3 (0.39) MAPTNPC1RAB9AENPP3ENPP1
SCHEMBL5041011 0.85 NPC1 (0.50) ALDH1A1MAPTNPC1RAB9AENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432417-A2 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2004-06-30 EP disclosed
WO-2003028721-A2 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER AVENTIS PHARMA S.A. (FR) 2003-04-10 WO disclosed